title: Using Plasmids as DNA Vaccines for Infectious Diseases.
abstract: DNA plasmids can be used to induce a protective (or therapeutic) immune response by delivering genes encoding vaccine antigens. That naked DNA (without the refinement of coat proteins or host evasion systems) can cross from outside the cell into the nucleus and be expressed is particularly remarkable given the sophistication of the immune system in preventing infection by pathogens. As a result of the ease, low cost, and speed of custom gene synthesis, DNA vaccines dangle a tantalizing prospect of the next wave of vaccine technology, promising individual designer vaccines for cancer or mass vaccines with a rapid response time to emerging pandemics. There is considerable enthusiasm for the use of DNA vaccination as an approach, but this enthusiasm should be tempered by the successive failures in clinical trials to induce a potent immune response. The technology is evolving with the development of improved delivery systems that increase expression levels, particularly electroporation and the incorporation of genetically encoded adjuvants. This review will introduce some key concepts in the use of DNA plasmids as vaccines, including how the DNA enters the cell and is expressed, how it induces an immune response, and a summary of clinical trials with DNA vaccines. The review also explores the advances being made in vector design, delivery, formulation, and adjuvants to try to realize the promise of this technology for new vaccines. If the immunogenicity and expression barriers can be cracked, then DNA vaccines may offer a step change in mass vaccination.
authors.affiliation: Mucosal Infection and Immunity Group, Section of Virology, Imperial College London, St Mary's Campus, London W2 1PG, United Kingdom.
authors.forename: John S
authors.initials: JS
authors.lastname: Tregoning
authors.affiliation: Mucosal Infection and Immunity Group, Section of Virology, Imperial College London, St Mary's Campus, London W2 1PG, United Kingdom.
authors.forename: Ekaterina
authors.initials: E
authors.lastname: Kinnear
mesh_terms: D002986:Clinical Trials as Topic; D003141:Communicable Diseases / Q000453:epidemiology*; D055808:Drug Discovery / Q000639:trends; D010957:Plasmids / Q000008:administration & dosage*; D014611:Vaccination / Q000379:methods*; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology*
chemical_list: D019444:Vaccines, DNA